Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 3/20 | 0.46 |
| ▸ | IGF1R | P08069 | 10/20 | 0.41 |
| ▸ | EGFR | P00533 | 8/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 7/20 | 0.41 |
| ▸ | KDR | P35968 | 5/20 | 0.41 |
| ▸ | RET | P07949 | 4/20 | 0.41 |
| ▸ | STK3 | Q13188 | 4/20 | 0.41 |
| ▸ | MAP4K5 | Q9Y4K4 | 4/20 | 0.41 |
| ▸ | AURKA | O14965 | 3/20 | 0.41 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.41 |
| ▸ | MAP4K4 | O95819 | 3/20 | 0.41 |
| ▸ | INSR | P06213 | 3/20 | 0.41 |
| ▸ | LCK | P06239 | 3/20 | 0.41 |
| ▸ | FYN | P06241 | 3/20 | 0.41 |
| ▸ | LYN | P07948 | 3/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.41 |
| ▸ | FLT4 | P35916 | 3/20 | 0.41 |
| ▸ | FRK | P42685 | 3/20 | 0.41 |
| ▸ | SYK | P43405 | 3/20 | 0.41 |
| ▸ | MAPK8 | P45983 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1641781 | 0.99 | IKBKB (0.45) | IKBKBIGF1REGFRERBB2KDR | |
| SCHEMBL12766967 | 0.95 | IKBKB (0.46) | IKBKBIGF1REGFRERBB2KDR | |
| Hydrochloric Acid SCHEMBL1640793 | 0.94 | IKBKB (0.45) | IKBKBIGF1REGFRERBB2KDR | |
| SCHEMBL12726573 | 0.83 | ALDH1A2 (0.43) | IGF1REGFRERBB2KDRRET | |
| Hydrochloric Acid SCHEMBL1641763 | 0.82 | ALDH1A2 (0.42) | IGF1REGFRERBB2KDRRET | |
| SCHEMBL12726553 | 0.80 | IGF1R (0.54) | IKBKBIGF1REGFRERBB2KDR | |
| SCHEMBL1641750 | 0.79 | IGF1R (0.51) | IKBKBIGF1REGFRERBB2KDR | |
| SCHEMBL1641950 | 0.79 | IKBKB (0.46) | IKBKBIGF1REGFRERBB2KDR | |
| SCHEMBL14073740 | 0.78 | NSD2 (0.56) | SMN1; SMN2MEN1POLBKMT2AALDH1A1 | |
| SCHEMBL12766425 | 0.77 | SYK (0.46) | IGF1REGFRERBB2KDRRET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110098296-A1 | Thiazole And Oxazole Kinase Inhibitors | GLAXOSMITHKLINE LLC | 2011-04-28 | — | — | US | disclosed |
| US-20110098296-A1 | Thiazole And Oxazole Kinase Inhibitors | GLAXOSMITHKLINE LLC | 2011-04-28 | — | — | US | disclosed |
| WO-2009076140-A1 | THIAZOLE AND OXAZOLE KINASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2009-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098296-A1 | Thiazole And Oxazole Kinase Inhibitors | PDXK, MAP3K1, MAP4K2 | IKBKB 471/4885IGF1R 396/4885EGFR 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.